PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33390555-2	2021	Nateglinide (NTG) was utilized as a model compound, since it is a hepatically-metabolized compound and its metabolism is mainly mediated by CYP 2C11 enzyme.	Nateglinide	0-11	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	140-148	
33390555-8	2021	These findings suggest that inflammation occurring in peripheral tissues brings about a decrease in hepatic NTG metabolism by suppressing the hepatic expression of CYP2C11 protein, causing an alteration of the plasma concentration profile of NTG with its impaired elimination.	Nateglinide	108-111	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	164-171	
33390555-8	2021	These findings suggest that inflammation occurring in peripheral tissues brings about a decrease in hepatic NTG metabolism by suppressing the hepatic expression of CYP2C11 protein, causing an alteration of the plasma concentration profile of NTG with its impaired elimination.	Nateglinide	242-245	cytochrome P450, subfamily 2, polypeptide 11	Rattus norvegicus	164-171